Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia

NCT00425815 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00425815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2009
Completion date
April 30, 2009
Enrollment
0 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia